Disclosures Raymond U. Osarogiagbon reports a relationship with National Cancer Institute that includes: board membership, consulting or advisory; with BridgeBio that includes: equity or stocks; with Eli Lilly that includes: equity or stocks; with Gilead Sciences that includes: equity or stocks; with Immunocore that includes: equity or stocks; with Pfizer that includes: equity or stocks; with AstraZeneca that includes: consulting or advisory and speaker and lecture fees; with GE Healthcare that includes: consulting or advisory; and with Median Technologies that includes: consulting or advisory; and holds a patent for a lymph node specimen collection kit and method of lymph node collection. Sora Ely declares that she has no conflicts of interest to disclose.